Department of Medicine, University of Illinois, Chicago, IL, USA.
Nephrol Dial Transplant. 2013 Aug;28(8):2156-60. doi: 10.1093/ndt/gfs115. Epub 2012 May 4.
To measure adequacy in patients dialyzed other than three times per week, guidelines recommend the use of 'standard' Kt/V, which commonly is estimated from treatment Kt/V, time and frequency; however, the accuracy of equations that predict treatment Kt/V in patients being dialyzed other than three times per week has not been evaluated.
In patients enrolled in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials who were being dialyzed three, four or six times per week, we tested the accuracy of the following Kt/V prediction equation: Kt/V = -ln(R - GFAC × T_hours) + (4-3.5 × R) × 0.55 × weight loss/V, where R = post-dialysis/pre-dialysis blood urea nitrogen and GFAC, originally set to 0.008 for a 3/week schedule (Daugirdas, J Am Soc Nephrol 1993), is a factor that adjusts for urea generation.
With the above equation, there was <0.1% mean error in predicted treatment Kt/V for 3/week patients, but mean errors were -5, -9 and -13% for the 6/week daily, 4/week nocturnal and 6/week nocturnal patients. Modeling simulations were performed to optimize the GFAC term for dialysis schedule and length of the preceding interdialysis interval (PIDI). After substituting schedule- and interval-optimized GFAC terms, the treatment Kt/V prediction errors were reduced to -0.81, +0.1 and -1.3% for the three frequent dialysis schedules tested.
For frequent dialysis schedules, the urea generation factor (GFAC) of one commonly used Kt/V prediction equation should be adjusted based on length in days of the PIDI and number of treatments per week.
为了衡量每周透析三次以上患者的透析充分性,指南建议使用“标准”Kt/V,该值通常根据治疗 Kt/V、时间和频率来估算;然而,尚未评估预测每周透析三次以上患者治疗 Kt/V 的方程的准确性。
在每周接受三次、四次或六次透析的 Frequent Hemodialysis Network(FHN)每日和夜间试验入组患者中,我们检验了以下 Kt/V 预测方程的准确性:Kt/V = -ln(R - GFAC × T_hours) + (4-3.5 × R) × 0.55 × weight loss/V,其中 R = 透析后/透析前血尿素氮,GFAC 最初设定为每周三次透析方案的 0.008(Daugirdas,J Am Soc Nephrol 1993),是一个调整尿素生成的因子。
应用上述方程,每周透析三次患者的预测治疗 Kt/V 平均误差<0.1%,但每日六次透析、每周四次夜间透析和每周六次夜间透析患者的平均误差分别为-5%、-9%和-13%。为了优化透析方案和透析前间隔时间(PIDI)长度的 GFAC 项,进行了模型模拟。替代优化后的方案和间隔 GFAC 项后,三种频繁透析方案的治疗 Kt/V 预测误差分别减少至-0.81%、+0.1%和-1.3%。
对于频繁的透析方案,应根据 PIDI 的天数和每周治疗次数来调整一种常用 Kt/V 预测方程的尿素生成因子(GFAC)。